Multidrug resistant bacteria market to reach $18.77 billion by 2030 at 7.4% cagr, driven by increasing prevalence of infectious diseases.
Read More
Mucolipidosis ii market to reach $16.19 billion by 2030 at 3.5% CAGR, driven by rise in gene therapy, increased research and development activities, and growing number of clinical trials.
Read More
Mtor inhibitors market to reach $10.39 billion by 2030 at 6.2% CAGR, driven by rise in prevalence of kidney diseases.
Read More
The global Msi-h and dmmr market to reach $21.13 billion by 2030 at 22.7% CAGR, driven by rising prevalence of cancer.
Read More
Mrna therapeutics cdmo market to reach $8.26 billion by 2030 at 11.7% CAGR, driven by growing burden of chronic and infectious diseases.
Read More
Mrna therapeutics market to reach $42.32 billion by 2030 at 3.3% CAGR, driven by increasing prevalence of long-lasting and communicable diseases.
Read More
Mrna cancer vaccines and therapeutics market to reach $141.51 billion by 2030 at 14.4% CAGR, driven by rising prevalence of cancer.
Read More
Morphine drugs market to reach $30.17 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of chronic pain conditions.
Read More
The global montelukast sodium market to reach $6.33 billion by 2030 at 8.4% CAGR, driven by increasing prevalence of asthma.
Read More
Monoclonal antibody therapeutics market to reach $396.1 billion by 2030 at 11.9% CAGR, driven by rising prevalence of autoimmune diseases.
Read More